News
Regeneron Pharmaceuticals, Inc. saw a significant boost this quarter, with Mitsubishi UFJ Asset Management Co. Ltd. upping ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) awarded the 13th annual Regeneron Prize for ...
Shares of Regeneron Pharmaceuticals Inc. slipped 3.03% to $545.94 Monday, on what proved to be an all-around poor trading ...
10h
Stocktwits on MSNThis Stock Has Tumbled 50% In One Year, Gets A Price Target Cut Today – But Retail Believes $400-450 Is A Good Entry Point
Truist on Monday lowered its price target on Regeneron (REGN) to $812 from $940, citing concerns with the company’s Eylea ...
Moving on, Regeneron’s second-quarter report was largely positive. Total revenues of $3.68 billion (up 4% YoY) beat analyst ...
Regeneron Court Permits Government to Pursue False Certification Theory - On August 4, the district court in the closely ...
Patients with psoriasis have significantly more difficulty sleeping, particularly in new environments, than matched ...
According to Benzinga Pro, Regeneron Pharmaceuticals's peer group average for short interest as a percentage of float is 6.13 ...
The growing healthcare burden posed by hepatocellular carcinoma, the most common subtype of liver cancer, has prompted the ...
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds ...
The close-knit South Shore village scored points for its strong public schools, quick commute to NYC and nearby beach access, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results